Filing Details
- Accession Number:
- 0001562180-19-005642
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-11-22 06:20:19
- Reporting Period:
- 2019-11-20
- Accepted Time:
- 2019-11-22 06:20:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1517022 | Akebia Therapeutics Inc. | AKBA | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1379970 | C Steven Gilman | C/O Akebia Therapeutics, Inc. 245 First St. Cambridge MA 02142 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-11-20 | 5,800 | $3.43 | 29,731 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The purchase reported in this Form 4 was made on the open market.
Billionaire Hedge Funds
